PicoSure Cleared by FDA To Treat Acne Scars

The PicoSure picosecond laser from Cynosure has received FDA clearance for the treatment of acne scars. In clinical studies, 77% of patients achieved greater than 50% improvement as graded by the physician. In addition, PicoSure received a 97% physician satisfaction rate at the one-month follow up appointment and increased to 100% at the three-month follow up. PicoSure received a 76% patient satisfaction rate at the one-month follow up appointment and increased to 86% patient satisfaction rate at the three-month follow up.

"PicoSure's PressureWave technology gently delivers ultra-short pulses of energy in trillionths of a second resulting in increased density and length of elastin fibers and increased collagen deposition," said Jeremy Brauer, MD, of Laser & Skin Surgery Center of New York. Based on results from Cynosure's clinical study, these are very positive signs to restoring normal skin elasticity in the scar tissue and thus reducing the appearance of the scar.

More in News